Eupalinolide B inhibits hepatic carcinoma by inducing ferroptosis and ROS-ER-JNK pathway

Primary hepatic carcinoma is a common malignant tumor. The classic molecular targeted drug sorafenib is costly and is only effective for some patients. Therefore, it is of great clinical significance to search for new molecular targeted drugs. Eupalinolide B (EB) from Eupatorium lindleyanum DC. is used to treat chronic tracheitis in clinical practice. However, the role of EB in hepatic carcinoma is unknown. In this study, we first measure the effect of EB on tumor growth in a xenograft model and PDX model. The cell proliferation and migration are also detected in human hepatocarcinoma cell lines (SMMC-7721 and HCCLM3). Then, we investigate cell cycle, cell apoptosis, cell necrosis, cell autophagy, and ferroptosis by flow cytometry, western blot analysis and electron microscopy. The results demonstrate that EB exerts anti-proliferative activity in hepatic carcinoma by blocking cell cycle arrest at S phase and inducing ferroptosis mediated by endoplasmic reticulum (ER) stress, as well as HO-1 activation. When HO-1 is inhibited, EB-induced cell death and ER protein expression are rescued. The migration-related mechanism consists of activation of the ROS-ER-JNK signaling pathway and is not connected to ferroptosis. In summary, we first discover that EB inhibits cell proliferation and migration in hepatic carcinoma, and thus EB is a promising anti-tumor compound that can be used for hepatic carcinoma.

[1]  Jichuang Wang,et al.  Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1‐mediated EMT , 2021, Molecular carcinogenesis.

[2]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[3]  Xueyi Wang,et al.  Traditional Applications, Phytochemistry, and Pharmacological Activities of Eupatorium lindleyanum DC.: A Comprehensive Review , 2020, Frontiers in Pharmacology.

[4]  Aleksandra A. Kolodziejczyk,et al.  The cell cycle in stem cell proliferation, pluripotency and differentiation , 2019, Nature Cell Biology.

[5]  N. Abraham,et al.  HO-1 overexpression and underexpression: Clinical implications. , 2019, Archives of biochemistry and biophysics.

[6]  O. Bouché,et al.  Pravastatin combination with Sorafenib does not improve survival in advanced Hepatocellular Carcinoma. , 2019, Journal of hepatology.

[7]  M. D'Arcy.  Cell death: a review of the major forms of apoptosis, necrosis and autophagy , 2019, Cell biology international.

[8]  D. Montell,et al.  Unconventional Ways to Live and Die: Cell Death and Survival in Development, Homeostasis, and Disease. , 2018, Annual review of cell and developmental biology.

[9]  H. Cui,et al.  Demethylzeylasteral inhibits glioma growth by regulating the miR-30e-5p/MYBL2 axis , 2018, Cell Death & Disease.

[10]  J. Llovet,et al.  Molecular therapies and precision medicine for hepatocellular carcinoma , 2018, Nature Reviews Clinical Oncology.

[11]  B. Stockwell,et al.  Regulation of lipid peroxidation and ferroptosis in diverse species , 2018, Genes & development.

[12]  S. Bhat,et al.  A review on heme oxygenase-1 induction: is it a necessary evil , 2018, Inflammation Research.

[13]  F. Liu,et al.  GDF11/BMP11 as a novel tumor marker for liver cancer. , 2018, Experimental and therapeutic medicine.

[14]  Wei‐Chao Chang,et al.  Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis. , 2018, Cancer letters.

[15]  H. Cui,et al.  Demethylzeylasteral inhibits cell proliferation and induces apoptosis through suppressing MCL1 in melanoma cells , 2017, Cell Death and Disease.

[16]  H. El‐Serag,et al.  Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma , 2017, Cancer control : journal of the Moffitt Cancer Center.

[17]  M. Conrad,et al.  Iron and ferroptosis: A still ill‐defined liaison , 2017, IUBMB life.

[18]  M. Nitti,et al.  HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation , 2017, Antioxidants.

[19]  Huajun Zhao,et al.  Eupalinolide O, a novel sesquiterpene lactone from Eupatorium lindleyanum DC., induces cell cycle arrest and apoptosis in human MDA-MB-468 breast cancer cells. , 2016, Oncology reports.

[20]  Dao-feng Chen,et al.  Eupatorium lindleyanum DC. flavonoids fraction attenuates lipopolysaccharide-induced acute lung injury in mice. , 2016, International immunopharmacology.

[21]  Nai-yu Xu,et al.  Eupatorium lindleyanum DC. sesquiterpenes fraction attenuates lipopolysaccharide-induced acute lung injury in mice. , 2016, Journal of ethnopharmacology.

[22]  Q. Shi,et al.  Chemical Constituents of Plants from the Genus Eupatorium (1904–2014) , 2015, Chemistry & biodiversity.

[23]  Min‐Young Kwon,et al.  Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death , 2015, Oncotarget.

[24]  J. Llovet,et al.  Advances in targeted therapies for hepatocellular carcinoma in the genomic era , 2015, Nature Reviews Clinical Oncology.

[25]  L. Galluzzi,et al.  Decoding cell death signals in liver inflammation. , 2013, Journal of hepatology.

[26]  P. Dent,et al.  Lapatinib and Obatoclax Kill Breast Cancer Cells through Reactive Oxygen Species-Dependent Endoplasmic Reticulum Stress , 2012, Molecular Pharmacology.

[27]  Lyora A. Cohen,et al.  Endoplasmic reticulum anchored heme-oxygenase 1 faces the cytosol , 2012, Haematologica.

[28]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[29]  Yonghong Hu,et al.  Antioxidant Activities of Extracts and Fractions from Eupatorium lindleyanum DC , 2011, Molecules.

[30]  J. Seong,et al.  Radiation‐induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinoma , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[31]  J. Yue,et al.  Cytotoxic sesquiterpene lactones from Eupatorium lindleyanum. , 2004, Journal of natural products.